在2型糖尿病患者的牙周治疗中的辅助黑激素:系统性审查和元分析
Pedro Sampaio1, Saife Muhsin2, Ahmad Shoeb Hashmi3
1Faculdade de Odontologia do Recife, Rua Artur Coutinho, 143 - Santo Amaro, Recife - PE, Pernambuco, 50100-280 Brazil.
Journal of diabetes and metabolic disorders
|October 20, 2025
概括
在2型糖尿病患者中,补充黑色素显著改善了牙周健康. 这一元分析显示了探测深度,临床附着水平和探测出血的好处,表明了潜在的辅助疗法.
科学领域:
- 牙周病学 牙周病学
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 黑素具有抗炎和抗氧化特性,有利于牙周治疗.
- 黑激素作为2型糖尿病患者牙周炎的辅助疗法的疗效尚未得到充分证实.
- 这一元分析研究了黑激素在这个特定的患者群体中的临床影响.
研究的目的:
- 为了评估黑激素作为2型糖尿病患者牙周炎的辅助治疗的有效性.
- 与单独标准治疗相比,评估辅助黑激素对关键牙周指标的影响.
主要方法:
- 在PubMed,Embase和Cochrane图书馆进行了系统的文献搜索,截至2025年6月.
- 包括的研究比较了2型糖尿病和牙周炎患者的SRP单独或安慰剂的辅助黑激素加缩和根平 (SRP).
- 主要结局包括探测深度 (PD),临床附着水平 (CAL) 和探测出血 (BOP);斑块指数 (PI) 是次要结局. 分析使用随机效应模型,并使用Cochrane RoB 2工具评估偏差风险.
主要成果:
- 四项涉及269名参与者的研究被纳入了元分析.
- 辅助黑激素显著降低了探测深度 (MD: -1.38 mm) 和改善了临床附着水平 (MD: -1.17 mm).
- 探测时的出血也显著减少 (RR:0.68),描述性分析偏好了黑色素对斑块指数的偏好.
结论:
- 辅助黑激素在临床牙周指标上显著改善,并减少2型糖尿病和牙周炎患者的炎症.
- 黑素显示出作为一种生物学上可信且耐受良好的辅助疗法的潜力.
- 由于目前的证据有限,需要进一步进行高质量的临床试验来证实这些发现.
相关概念视频
01:19Management of Insomnia
528
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
528
01:22Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
01:15Diabetes: Management and Pharmacotherapy
861
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
861